Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ZOLMITRIPTAN TABLET

Closed
SPE2DP-26-T-4602Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs Enterprise Procurement Office intends to issue Request for Proposal 36E79727R0039 for an unrestricted procurement of Latanoprost Ophthalmic Solution. This contract will establish an uninterrupted source of supply for the VA, including Consolidated Mail Order Pharmacies and Option 2 State Veterans Homes, as well as the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DoD. The award will be granted to a single responsible offeror for a base period of one year with four pre-priced one-year option periods. The solicitation is expected to be issued in commercial item format per FAR Part 12 on approximately October 21, 2026, with a tentative closing date of November 4, 2026, under NAICS code 325412. Strict labeling and packaging requirements apply to this procurement. Offerors must provide the exact drug name as it appears on the label and a unique NDC number. The contractor's label must be the sole label on the product, and affixing labels over existing ones is prohibited; however, the label must allow VA labels to adhere securely on top. Additionally, vendors must comply with the American Academy of Ophthalmology’s recommended uniform color-coding system for the caps and labels of all topical ocular medications. This acquisition is subject to the World Trade Organization Government Procurement Agreement and Free Trade Agreements. All communications and submissions are to be handled electronically via SAM.gov, with James Sullivan serving as the primary point of contact.
Nac Pharmaceuticals (36E797)

POSTED

about 10 hours ago

DEADLINE

in 18 days

AI Contract Overview

Show more

This contract is for the procurement of Zolmitriptan 2.5 mg rapidly disintegrating tablets used in the treatment of migraines. The medication is supplied in individually sealed blister packs, with the unit of issue defined as a package of six tablets. The product must be stored at controlled room temperature between 20C and 25C and protected from light and moisture, with dispensing required in tight, light-resistant closed containers. The agreement specifies a non-extendable shelf life of 36 months and requires adherence to Medical Marking Standard No. 1 and DLA packaging requirements. Delivery is set for five days after the order, with the destination serving as the point for both inspection and acceptance. This FDA-regulated drug is managed under NSN 6505015230353 and is associated with the Department of Defense Medical Supply Chain Pharmacy.

General Info

Procurement of Zolmitriptan 2.5mg tablets for migraines via DoD Medical Supply Chain Pharmacy.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

331 SIJAN AVE, WHITEMAN AFB, MO, 65305-1269, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Solicitation

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
ZOLMITRIPTAN TABLET
ZOLMITRIPTAN TABLETS, 2.5 MG, 6'S
.
2.5 MG, RAPIDLY DISINTEGRATING TABLETS, INDIVIDUALLY SEALED; BLISTER
PACK; USED IN TREATMENT OF MIGRAINES. AMERICAN HOSPITAL FORMULARY
SERVICE CLASSIFICATION NUMBER: 28:92.00.
.
UNIT OF ISSUE: PACKAGE (PG) OF 6EA
.
STORE AT 20°C TO 25°C (68°F TO 77°F) [SEE USP CONTROLLED ROOM
TEMPERATURE]. PROTECT FROM LIGHT AND MOISTURE. DISPENSE IN A TIGHT,
LIGHT-RESISTANT CLOSED CONTAINER.
.
SHALL BE MARKED IAW THE LATEST EDITION OF MEDICAL MARKING STANDARD NO. 1
HTTPS://WWW.DLA.MIL/LOGISTICS-OPERATIONS/PACKAGING/
.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. . .. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
AVKARE LLC 4QGW8 P/N NDC42291-0998-06 JUBILANT CADISTA PHARMACEUTICALS INC. 441M0 P/N NDC59746-0461-16
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4602
SECTION B
PR: 7017815348 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017815348 0001 PG 1.000
NSN/MATERIAL:6505015230353
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-523-0353 Quantity: 1 PG Purchase Request: 7017815348QTY: 1 Delivery: 5 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS